U.S. Physical Therapy Inc. (NYSE:USPH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Thursday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other brokerages have also issued reports on USPH. Barrington Research lowered U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, August 5th. Jefferies Group set a $65.00 price objective on U.S. Physical Therapy and gave the stock a “hold” rating in a report on Friday, August 5th.

U.S. Physical Therapy (NYSE:USPH) opened at 63.61 on Thursday. The firm has a market capitalization of $796.40 million, a price-to-earnings ratio of 32.79 and a beta of 0.72. The company has a 50-day moving average price of $62.87 and a 200 day moving average price of $57.77. U.S. Physical Therapy has a 1-year low of $43.18 and a 1-year high of $64.89.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, August 4th. The company reported $0.57 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.55 by $0.02. The business earned $90.40 million during the quarter, compared to analysts’ expectations of $90.01 million. U.S. Physical Therapy had a return on equity of 12.06% and a net margin of 6.95%. U.S. Physical Therapy’s revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.51 earnings per share. Equities analysts anticipate that U.S. Physical Therapy will post $1.99 earnings per share for the current year.

In related news, CEO Christopher J. Reading sold 8,000 shares of the stock in a transaction on Monday, September 19th. The stock was sold at an average price of $64.01, for a total transaction of $512,080.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the stock in a transaction on Friday, August 5th. The stock was sold at an average price of $59.60, for a total value of $119,200.00. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Bank of Montreal Can purchased a new stake in shares of U.S. Physical Therapy during the second quarter valued at about $14,047,000. Perkins Capital Management Inc. bought a new position in U.S. Physical Therapy during the second quarter valued at $437,000. Albert D Mason Inc. raised its position in U.S. Physical Therapy by 0.5% in the second quarter. Albert D Mason Inc. now owns 30,544 shares of the company’s stock valued at $1,839,000 after buying an additional 147 shares during the period. Eqis Capital Management Inc. raised its position in U.S. Physical Therapy by 0.6% in the second quarter. Eqis Capital Management Inc. now owns 18,914 shares of the company’s stock valued at $1,139,000 after buying an additional 107 shares during the period. Finally, Capstone Asset Management Co. raised its position in U.S. Physical Therapy by 12.7% in the second quarter. Capstone Asset Management Co. now owns 6,743 shares of the company’s stock valued at $406,000 after buying an additional 760 shares during the period. Institutional investors and hedge funds own 98.33% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.